RecruitingNCT02270476

Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn Screening


Sponsor

Heidelberg University

Enrollment

200 participants

Start Date

Dec 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to further characterize early CF lung disease in newborns, infants and toddlers with cystic fibrosis (CF).


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cystic fibrosis lung disease. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

University Children's Hospital Heidelberg, Cystic Fibrosis Centre

Heidelberg, Baden-Wurttemberg, Germany

University Hospital Gießen and Marburg GmbH

Giessen, Hesse, Germany

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany

University Children's Hospital Schleswig-Holstein

Lübeck, Schleswig-Holstein, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02270476